Report Details
The Meningococcal Vaccines Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for co…
Report Details
The HIV and HBV Therapies Market Report 2022-2032: This report will prove valuable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for compa…
Mouth Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Drug Class (Antimicrobial, Antihistamine, Analgesics & Corticosteroids, Others), By Formulation (Mouthwash, Lozenges, Ointment, Spray, Gel), By Indication (Aphthous Stomatitis, Oral Lichen Planus, Others), By Region
The global mouth ulcer treatment market expected to witness a steady growth during the forecast period. This can be ascribed to the growing prevalence of mouth ulcers among population worldwide. Mouth ulcers are basically sores that are formed on the soft…
Executive Summary
According to Azoth Analytics research report, the Therapeutic Monoclonal Antibodies Market is projected to display significant growth represented by a CAGR of 18.63% during 2022–2028. The Global Therapeutic Monoclonal Antibodies Market …
Executive Summary
According to a research report published by Azoth Analytics in November 2022, the Global Biosimulation Market was valued at USD 3011.50 Million in the year 2021. Biosimulation helps to increase the probability of success in human clinic…
Lactase Market by Source (Yeast, Fungi, and Bacteria), Form (Liquid and Dry), Application (Food & Beverages and Pharmaceutical products & Dietary Supplements), Region (North America, Europe, Asia Pacific, South America and RoW) - Global Forecast to 2027
According to MarketsandMarkets, the global lactase market is estimated to be valued at USD 247 million in 2022. It is projected to reach USD 336 million by 2027, at a CAGR of 6.3%, in terms of value, between 2022 and 2027. The market is gaining momentum w…
The global recombinant proteins market is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the forecast period. The market growth is primarily driven by factors such as increasing government investments an…
Global Acute Ischemic Stroke Therapeutics Market 2023-2027Technavio has been monitoring the acute ischemic stroke therapeutics market and it is poised to grow by $1524.49 mn during 2023-2027, accelerating at a CAGR of 5.72% during the forecast period. Our…
Global Gastrointestinal Stromal Tumors Therapeutics Market 2022-2026Technavio has been monitoring the gastrointestinal stromal tumors therapeutics market and it is poised to grow by $1.08 bn during 2022-2026, accelerating at a CAGR of 5.97% during the for…
Global Interventional Oncology Market 2022-2026Technavio has been monitoring the interventional oncology market and it is poised to grow by $ 1.03 bn during 2022-2026, accelerating at a CAGR of 7.49% during the forecast period. Our report on the intervent…
Global Women's Health Therapeutics Market 2022-2026Technavio has been monitoring the women's health therapeutics market and it is poised to grow by $ 30.35 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period. Our report on the …
Global Open-Angle Glaucoma Therapeutics Market 2022-2026Technavio has been monitoring the open-angle glaucoma therapeutics market and it is poised to grow by $ 2.58 bn during 2022-2026, accelerating at a CAGR of 7.18% during the forecast period. Our repor…
Global Chronic Myelogenous Leukemia Therapeutics Market 2022-2026Technavio has been monitoring the chronic myelogenous leukemia therapeutics market and it is poised to grow by $ 2.14 bn during 2022-2026, accelerating at a CAGR of 6.1% during the forecast …
Global Alpha Glucosidase Inhibitors Market 2022-2026Technavio has been monitoring the alpha glucosidase inhibitors market and it is poised to grow by $ 567.96 mn during 2022-2026, accelerating at a CAGR of 2.51% during the forecast period. Our report on t…
Global Age-related Macular Degeneration Market 2022-2026Technavio has been monitoring the age-related macular degeneration market and it is poised to grow by $ 9.37 bn during 2022-2026, accelerating at a CAGR of 12.6% during the forecast period. Our repor…
Global PD-1 And PD-L1 Inhibitors Market 2022-2026Technavio has been monitoring the PD-1 and PD-L1 inhibitors market and it is poised to grow by $ 49.34 bn during 2022-2026, accelerating at a CAGR of 19.31% during the forecast period. Our report on the PD-…
Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2022-2026Technavio has been monitoring the age-related macular degeneration (AMD) therapeutics market and it is poised to grow by $ 9.37 bn during 2022-2026, accelerating at a CAGR of 12.6%…
Global Gastrointestinal Diseases Therapeutics Market 2022-2026Technavio has been monitoring the gastrointestinal diseases therapeutics market and it is poised to grow by $ 1.60 bn during 2022-2026, accelerating at a CAGR of 6.68% during the forecast perio…
Global Eczema Therapeutics Market 2022-2026Technavio has been monitoring the eczema therapeutics market and it is poised to grow by $ 4.36 bn during 2022-2026, accelerating at a CAGR of 9.6% during the forecast period. Our report on the eczema therapeutic…
Rabies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rabies - Drugs In Development, 2022, provides an overview of …